Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Brazil

 

Notre Dame Intermedica looking to raise $775m with new share issue

Grupo Notre Dame Intermedica (GNDI), one of Brazil's largest hospital groups, is hoping to raise around R$3bn ($775m) from the sale of new shares this month. We speak to a Brazilian healthcare expert to find out what this means for the company and investors.

Diaverum grows in Brazil through acquisitions

International dialysis provider Diaverum has expanded in Brazil with the acquisition of three clinics following its initial entry into Latin America's largest market in January, 2018.

Sodexo acquires medicalised home care in Brazil

Sodexo, a French catering and facilities maintenance expert, has entered the Brazilian domiciliary care market with the acquisition of a medicalised homecare specialist. We speak to a Brazilian healthcare director at KPMG.

FREE BLOG Why Brazil is following in America’s footsteps

Donald Trump isn't the only president on the other side of the Atlantic to turn a nation's political landscape on its head. Brazil's new populist president, Jair Bolsonaro, shocked pundits the world over by bagging the presidency - and showed the world he can be as vitriolic as his US counterpart, too. But the business world likes him.

Quest Diagnostics changes strategy in emerging markets

Last week Healthcare Nova reported that US-based lab company Quest Diagnostics had sold its Indian medical diagnostics arm to Strand Life Sciences. We also reported that Quest has set up an international alliance of lab companies based in Brazil, Saudi Arabia, Korea, Hong Kong and Australia. Are the two moves connected? We speak to Quest's MD of global markets, Mark Machulcz to find out more about the group's change of strategy.

Brazil’s Bolsonaro would be “good news for private healthcare”

With 59% voter support, right-wing presidential candidate Jair Bolsonaro is leading Brazil's polls with only 12 days left before the final vote. What would a win for Bolsonaro mean for Brazilian private healthcare? We speak to market insider Marcelo Fonseca about the potential changes.

Find Us